Skip to main content
Top
Published in: Cancer Immunology, Immunotherapy 3/2012

01-03-2012 | Meeting report

Advances in cellular therapy: 6th international symposium on the clinical use of cellular products, March 24 and 25, 2011, Erlangen, Germany

Authors: Evelyn Ullrich, Jacobus Bosch, Michael Aigner, Simon Voelkl, Irena Kroeger, Petra Hoffmann, Marina Kreutz, Diana Dudziak, Armin Gerbitz

Published in: Cancer Immunology, Immunotherapy | Issue 3/2012

Login to get access

Excerpt

“Cellular Therapy 2011”: The 6th International Symposium on the Clinical Use of Cellular Products was held in Erlangen, Germany, on March 24–25, 2011. Twelve years ago, the conference took place for the first time in Regensburg and was originally initiated by Andreas Mackensen. Over the past years, it gained reputation and attracted leading researchers in the field from all over the world. This year’s conference was jointly organized at the University of Erlangen by the Department of Hematology & Oncology (Andreas Mackensen), the Department of Dermatology (Gerold Schuler), Erlangen, and the Department of Hematology & Oncology, Regensburg (Reinhard Andreesen). In principal, the “Cellular Therapy Meeting” aims at providing a multidisciplinary forum for basic and clinical researchers to communicate and to learn about the broad scope of cell therapy from different perspectives. The two-day meeting was attended by approximately 400 international participants and included sessions in the field of immune effector cells (T cells and NK cells), regulatory cells (Treg and MSC), antigen-presenting cells, cancer vaccination, gene-based cellular therapy, metabolism as well as regulatory issues and clinical applications of cellular therapy. These topics were presented by talks from 23 invited international experts. In addition, 20 short talks selected from abstracts of highest scientific quality and almost 130 posters were presented at the meeting. In this report, we summarize the most important research findings and highlight the main discussion topics of the plenary sessions. …
Metadata
Title
Advances in cellular therapy: 6th international symposium on the clinical use of cellular products, March 24 and 25, 2011, Erlangen, Germany
Authors
Evelyn Ullrich
Jacobus Bosch
Michael Aigner
Simon Voelkl
Irena Kroeger
Petra Hoffmann
Marina Kreutz
Diana Dudziak
Armin Gerbitz
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
Cancer Immunology, Immunotherapy / Issue 3/2012
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-011-1190-4

Other articles of this Issue 3/2012

Cancer Immunology, Immunotherapy 3/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine